TFF Pharmaceuticals CEO Glenn Mattes' 2022 pay slips 20% to $475K
TFF Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: October 4, 2023
TFF Pharmaceuticals reported fiscal year 2022 executive compensation information on October 4, 2023.
In 2022, four executives at TFF Pharmaceuticals received on average a compensation package of $313K, a 43% decrease compared to previous year.
Average pay of disclosed executives at TFF Pharmaceuticals
Glenn Mattes, Chief Executive Officer, received $475K in total, which decreased by 20% compared to 2021. 100% of Mattes' compensation, or $475K, was in salary.
Kirk Coleman, Chief Financial Officer, received a compensation package of $382K, which increased by 1% compared to previous year. 81% of the compensation package, or $310K, was in salary.
Christopher Cano, Chief Operating Officer, earned $354K in 2022, a 47% decrease compared to previous year.
Harlan Weisman, Chief Executive Officer, received $42K in 2022.
Related executives
You may also like
Source: SEC filing on October 4, 2023.